Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SURE-1: Sulopenem-etzadroxil/probenecid vs Ciprofloxacin in uUTI
NCT03354598Phase 3Completed
- Sponsor
- Iterum Therapeutics plc
- Start
- Aug 2018
- Primary completion
- Jan 2020
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sulopenem etzadroxil in urinary tract infection (UTI), sponsored by Iterum Therapeutics plc. Started Aug 2018; status: completed.
02
Drugs
sulopenem etzadroxil
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT03354598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03354598.